| Fannie H Fang, MD | |
|
1001 Jones St, Reno, NV 89503-5512 | |
| (775) 322-1880 | |
| (775) 322-1987 |
| Full Name | Fannie H Fang |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1001 Jones St, Reno, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174795041 | NPI | - | NPPES |
| 002016499 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 16196 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Fannie H Fang, MD 1001 Jones St, Reno, NV 89503-5512 Ph: (775) 322-1880 | Fannie H Fang, MD 1001 Jones St, Reno, NV 89503-5512 Ph: (775) 322-1880 |
News Archive
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.
ARCA biopharma, Inc. today announced that it has submitted a study protocol for review under the U.S. Food and Drug Administration's (FDA) Special Protocol Assessment (SPA) process for the design of a clinical trial to assess the safety and efficacy of GencaroTM, in approximately 3,000 patients with chronic heart failure who have the genotype that appears to respond most favorably to Gencaro. Gencaro is the Company's investigational, pharmacologically unique beta-blocker and mild vasodilator.
Estech, a leader in minimally invasive and endoscopic cardiac ablation, announced today that the Food and Drug Administration (FDA) has given conditional Investigational Device Exemption (IDE) approval to initiate patient enrollment in the Estech-sponsored ATTAC-AF trial.
A recent research study has given new scientific evidence to the long-held empirical belief that elderberries possess antiviral activities. The research involved a specific, reproducible elderberry extract developed by HerbalScience Group LLC, and succeeded in identifying key chemical components of the extract that inhibited in vitro infection and were shown to bind directly to Human Influenza A (H1N1) virus particles. The binding blocked the ability of the viruses to enter host cells, and thereby effectively preventing H1N1 infection in vitro.
› Verified 6 days ago
Susan E. Chambers-sorensen, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 75 Pringle Way, Suite 300, Reno, NV 89502 Phone: 775-982-6020 Fax: 775-982-6021 | |
Dr. Sonia Budhecha, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 75 Pringle Way, 505, Reno, NV 89502 Phone: 775-982-5000 Fax: 775-982-3900 | |
Lindsay Koppinger, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10581 Double R Blvd, Reno, NV 89521 Phone: 775-324-0766 | |
Max Coppes, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 75 Pringle Way, Ste 505, Reno, NV 89502 Phone: 775-982-5000 Fax: 775-982-3900 | |
Lauren Lee Sandefur, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 901 E 2nd St Ste 201, Reno, NV 89502 Phone: 775-982-5000 Fax: 775-982-3971 | |
Meredith Reynolds, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1001 Jones St, Reno, NV 89503 Phone: 775-322-1880 Fax: 775-322-1808 | |
Dr. Lynn Marie Kinman, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2667 Enterprise Rd, Reno, NV 89512 Phone: 775-688-1341 Fax: 775-688-2984 |